Skip to main content

  • Intranet
  • News & Events
  • Careers
  • Give

Duke Human Vaccine Institute

  • About Us
    • History
    • Leadership
    • Faculty
    • Careers
    • Mentoring
    • Diversity and Inclusion
    • News & Events
    • Publications
    • Science Culture and Accountability
  • Programs and Centers
    • Duke Consortia for HIV/AIDS Vaccine Development
    • Collaborative Influenza Vaccine Innovation Centers
    • HIV Vaccine Research and Development
    • Collaboration for AIDS Vaccine Discovery
    • Duke Regional Biocontainment Laboratory
    • Duke Vaccine Trial Unit
    • Mother-Infant Health Programs
    • Immunology Virology Quality Assessment Center
    • Pandemic Preparedness Programs
  • Diseases & Research
    • Priority Pathogens
    • Shared Resources
    • Quantitative Research Division
    • Structural Biology Division
    • Good Manufacturing Practice Facility
Menu
  • About Us
    • History
    • Leadership
    • Faculty
    • Careers
    • Mentoring
    • Diversity and Inclusion
    • News & Events
    • Publications
    • Science Culture and Accountability
  • Programs and Centers
    • Duke Consortia for HIV/AIDS Vaccine Development
    • Collaborative Influenza Vaccine Innovation Centers
    • HIV Vaccine Research and Development
    • Collaboration for AIDS Vaccine Discovery
    • Duke Regional Biocontainment Laboratory
    • Duke Vaccine Trial Unit
    • Mother-Infant Health Programs
    • Immunology Virology Quality Assessment Center
    • Pandemic Preparedness Programs
  • Diseases & Research
    • Priority Pathogens
    • Shared Resources
    • Quantitative Research Division
    • Structural Biology Division
    • Good Manufacturing Practice Facility

Search form

News & Events

  • News
  • Announcements
  • Events
August 20, 2021

DDN: "Designing vaccines with reverse vaccinology"

Dr. Kevin Saunders

"Most vaccine development begins with looking at the pathogen. Scientists pinpoint key residues needed for the virus to enter the body and develop vaccines that train the body to recognize signatures of the foreign invader. Kevin O'Neil Saunders, associate professor of surgery and director of research at the Duke Human Vaccine Institute at Duke University develops vaccines after analyzing the body’s immune response to a pathogen. ..."

To read the full article from Drug Discovery News, click here.

Related

NPR: "Omicron evades Moderna vaccine too, study suggests, but boosters help"
Duke Health: "Duke Institute Lands Federal Contract to Make Vaccine Candidates"
The Washington Times: "Lab teams race to test vaccines’ strength against omicron variant"
NIH Director's Blog "Accelerating COVID-19 Vaccine Testing with ‘Correlates of Protection’"
WRAL: "Test developed at Duke can quickly tell who's got antibodies to fight which coronavirus variant"
Wired: "The Race Is On to Develop a Vaccine Against Every Coronavirus"
Popular Science: "Why are kids’ immune systems different from adults?"
WHQR: "Duke researchers helped pave the way for FDA panel to greenlight Covid-19 vaccine for young kids"
CBS17: "Mixing vaccines for boosters could produce higher antibody response, new study shows"
DDN: "Designing vaccines with reverse vaccinology"
Duke Human Vaccine Institute


Innovation, Collaboration, Excellence

  • About Us
  • Programs and Centers
  • Diseases & Research
  • Intranet
  • News & Events
  • Careers
  • Give
  • Contact Us
  • Terms & Conditions Policy

Stay Up To Date

Join our mailing list for the latest news, updates and more.

Duke Health School of Medicine Duke University
Copyright © 2004-2022 Duke University Health System